Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficiency and Safety Study of Pegylated Somatropin to Treat Growth Hormone Deficiency Children (PD)
This study has been completed.
Study NCT01342146   Information provided by GeneScience Pharmaceuticals Co., Ltd.

First Received on April 21, 2011.   Last Updated on May 9, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Growth Hormone Deficiency
Additional conditions recognized in this trial
Dwarfism, Pituitary
Endocrine System Diseases
More general conditions related to this trial
Bone Diseases
Bone Diseases, Developmental
Bone Diseases, Endocrine
Brain Diseases
Central Nervous System Diseases
Dwarfism
Hypopituitarism
Hypothalamic Diseases
Musculoskeletal Diseases
Nervous System Diseases
Pituitary Diseases
Interventions listed in this trial
pegylated Somatropin
Jintropin AQ
Additional drug interventions recognized in this trial
Hormones
More general drug interventions related to this trial
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
GeneScience Pharmaceuticals Co., Ltd.
Huazhong University of Science and Technology
First Affiliated Hospital, Sun Yat-Sen University
Capital Medical University
Children's Hospital of Fudan University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services